Yingli Wang

Dr. Yingli Wang represents clients at various stages in matters involving a broad range of technologies. Her practice includes procuring and managing global patent portfolios; strategic counseling on due diligence, patentability, and freedom to operate; inter partes review proceedings; and support in patent litigation. 

Yingli advises startups, public and private research institutions, and large public companies. Her experience spans biotechnology, pharmaceuticals, polymers and materials, and medical devices. She has additional experience with small molecules, nucleic acid, and antibody therapeutics; genetic diagnostics; nucleic acid sequencing and detection; chemical processes; polymers; and nanotechnology. 

Yingli was trained as a bio-organic and polymer chemist. Her doctoral research focused on the synthesis of modified DNA and the investigation of modification in DNA’s biological functions.